Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, has scheduled its second quarter 2025 financial results announcement for Wednesday, July 30, 2025. The results will be released before market opening, followed by a conference call at 8:30 a.m. ET.
Investors can access the conference call via phone (toll-free: 1-800-717-1738 or international: 1-646-307-1865) using conference ID 48251. A live webcast and presentation materials will be available on Anika's investor relations website, with an archived version accessible after the call.
[]Anika Therapeutics (NASDAQ: ANIK), azienda globale specializzata nella preservazione articolare e focalizzata sull'ortopedia a intervento precoce, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per mercoledì 30 luglio 2025. I risultati saranno diffusi prima dell'apertura dei mercati, seguiti da una conference call alle 8:30 a.m. ET.
Gli investitori potranno partecipare alla conference call telefonando (numero verde: 1-800-717-1738 o internazionale: 1-646-307-1865) utilizzando il codice ID conferenza 48251. Una diretta web e i materiali della presentazione saranno disponibili sul sito dedicato agli investitori di Anika, con una versione registrata accessibile dopo la chiamata.
Anika Therapeutics (NASDAQ: ANIK), una empresa global especializada en la preservación articular y enfocada en ortopedia de intervención temprana, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el miércoles 30 de julio de 2025. Los resultados se publicarán antes de la apertura del mercado, seguidos por una llamada conferencia a las 8:30 a.m. ET.
Los inversores pueden acceder a la llamada conferencia por teléfono (número gratuito: 1-800-717-1738 o internacional: 1-646-307-1865) usando el ID de conferencia 48251. Una transmisión en vivo y materiales de presentación estarán disponibles en el sitio web de relaciones con inversionistas de Anika, con una versión archivada accesible después de la llamada.
Anika Therapeutics (NASDAQ: ANIK)는 조기 개입 정형외과에 중점을 둔 글로벌 관절 보존 회사로, 2025년 2분기 재무 실적 발표를 2025년 7월 30일 수요일로 예정했습니다. 실적은 시장 개장 전 공개되며, 이후 동부 표준시 오전 8:30에 컨퍼런스 콜이 진행됩니다.
투자자들은 무료 전화(1-800-717-1738) 또는 국제 전화(1-646-307-1865)를 통해 회의 ID 48251을 사용하여 컨퍼런스 콜에 참여할 수 있습니다. 라이브 웹캐스트와 발표 자료는 Anika 투자자 관계 웹사이트에서 제공되며, 콜 종료 후에는 녹화본도 이용 가능합니다.
Anika Therapeutics (NASDAQ : ANIK), une entreprise mondiale spécialisée dans la préservation articulaire et axée sur l'orthopédie interventionnelle précoce, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le mercredi 30 juillet 2025. Les résultats seront publiés avant l'ouverture des marchés, suivis d'une conférence téléphonique à 8h30 (heure de l'Est).
Les investisseurs peuvent accéder à la conférence téléphonique par téléphone (numéro gratuit : 1-800-717-1738 ou international : 1-646-307-1865) en utilisant l'ID de conférence 48251. Un webcast en direct et les supports de présentation seront disponibles sur le site des relations investisseurs d'Anika, avec une version archivée accessible après l'appel.
Anika Therapeutics (NASDAQ: ANIK), ein globales Unternehmen für Gelenkerhalt mit Fokus auf frühzeitige orthopädische Interventionen, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Mittwoch, den 30. Juli 2025, geplant. Die Ergebnisse werden vor Börsenöffnung veröffentlicht, gefolgt von einer Telefonkonferenz um 8:30 Uhr ET.
Investoren können an der Telefonkonferenz über eine gebührenfreie Nummer (1-800-717-1738) oder international (1-646-307-1865) unter Verwendung der Konferenz-ID 48251 teilnehmen. Ein Live-Webcast und Präsentationsmaterialien stehen auf der Investor-Relations-Website von Anika zur Verfügung, mit einer archivierten Version nach der Konferenz.
- None.
- None.
BEDFORD, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2025 financial results before the opening of the market on Wednesday, July 30, 2025, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 48251. A live audio webcast and accompanying presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When will Anika Therapeutics (ANIK) release Q2 2025 earnings?
How can investors join Anika's Q2 2025 earnings call?
What time is Anika's Q2 2025 earnings conference call?
Where can I find Anika's Q2 2025 earnings presentation materials?
